CD274 and chordoma: Similarly, a 2016 study of the anti-PD-L1 antibody avelumab was investigated in four chordoma cell lines and demonstrated antibody-mediated cell cytotoxicity, particularly when co-incubated with brachyury-specific CD8+ T cells [83].